[go: up one dir, main page]

Mihlan et al., 2011 - Google Patents

Monomeric C‐reactive protein modulates classic complement activation on necrotic cells

Mihlan et al., 2011

View PDF @Full View
Document ID
18237134738033250405
Author
Mihlan M
Blom A
Kupreishvili K
Lauer N
Stelzner K
Bergström F
Niessen H
Zipfel P
Publication year
Publication venue
The FASEB Journal

External Links

Snippet

The acute‐phase protein C‐reactive protein (CRP) recruits C1q to the surface of damaged cells and thereby initiates complement activation. However, CRP also recruits complement inhibitors, such as C4b‐binding protein (C4bp) and factor H, which both block complement …
Continue reading at faseb.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—G01N2333/4701
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen

Similar Documents

Publication Publication Date Title
Mihlan et al. Monomeric C‐reactive protein modulates classic complement activation on necrotic cells
Xu et al. Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis
Zhang et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway
Björkqvist et al. Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III
Csincsi et al. FHR-1 binds to C-reactive protein and enhances rather than inhibits complement activation
JP6656926B2 (en) Evaluation, assay and treatment of pKal-related diseases
Skerka et al. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration
Mihlan et al. Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells
JP6757252B2 (en) Assay for determining plasma kallikrein biomarkers
Ramacciotti et al. Proteomics of microparticles after deep venous thrombosis
Simmelink et al. A simple method to discriminate between β2-glycoprotein I-and prothrombin-dependent lupus anticoagulants
Skjoedt et al. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation
Gardiner et al. Compromised ITAM‐based platelet receptor function in a patient with immune thrombocytopenic purpura
Wouters et al. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation
WO2016203053A2 (en) Methods of characterising cancer
Palm et al. Complement activation occurs at the surface of platelets activated by streptococcal M1 protein and this results in phagocytosis of platelets
KR20250084231A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in intervention and therapy of congestion in a patient in need thereof
US20090297508A1 (en) Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
Moroi et al. Activation‐induced changes in platelet surface receptor expression and the contribution of the large‐platelet subpopulation to activation
Charest-Morin et al. Comparing pathways of bradykinin formation in whole blood from healthy volunteers and patients with hereditary angioedema due to C1 inhibitor deficiency
Siudut et al. Impaired plasminogen binding in patients with venous thromboembolism: association with protein carbonylation
Palarasah et al. Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3
Luo et al. Effect of homocysteine on platelet activation induced by collagen
JP2016180665A (en) Detection method of heart failure by β-ANP
Antonipillai et al. LIM kinase 2 (LIMK2) may play an essential role in platelet function